Table 1.

Body Weight, Liver Weight, Liver/Body Weight Ratio and BAX/Bcl-2 in Control and All Treated Groups.^a

	Control	Lead Acetate	Vit-C	TUR	Vit-C + TUR
Body weight, gm	194.2 ± 6.8	175.6 ± 5.9	216.2 ± 4.6	173.4 ± 4.3	178 ± 6.7
Liver weight, gm	10.3 ± .3	6.4 ± 0.2b	9.8 ± 0.11c	8 ± 0.34d	7.8 ± 0.4d
Liver/body weight ratio, %	5.19 ± 0.28	3.6 ± 0.19e	4.56 ± 0.08f	4.6 ± 0.15f	4.4 ± 0.19
BAX/Bcl-2 ratio, %	12.6 ± 1	436.8 ± 26.7b	131.9 ± 2.7c	128.2 ± 6.7c	104.9 ± 3.8c

Abbreviations: Bcl-2, B-cell lymphoma-2; Bax, Bcl-2-associated X; TUR, turmeric.

^a Data are mean ± SEM (N = 6).

^b P ≤ .001 vs control.

^c P ≤ .001 vs lead-acetate injected group.

^d P ≤ .01 vs lead-acetate injected group.

^e P ≤ 0.01 vs control.

^f P ≤ .05 vs lead-acetate injected group.